Clinica Ocular is a self-described ophthalmological clinic.

Clinica Ocular

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Earl Bakken

Alfred E. Mann

Daniel Grossman

Palmer Hermundslie

Medtronic plc

Healionics is a company that has developed a novel vascular graft, STARgraft, aimed at providing safer and more reliable means of bloodstream access for dialysis in patients with kidney failure. The company's breakthrough biomaterial scaffold, STAR, has demonstrated superior resistance to occlusion and infection, addressing a severe unmet clinical need for long-term dialysis access.

Buddy Ratner

Max Maginness

Michel Alvarez

Andrew J Marshall

Healionics

The TEARS Foundation provides financial assistance and bereavement care for families who have lost a child, including support groups and peer companions. It self-describes as offering comprehensive grief support.

Metric
Company Name	Clinica Ocular	Medtronic plc	Healionics	The TEARS Foundation
Symbol		MDT
MSH ID	CO:COM:CLINICAINSTITUTOOCULAR	COM:MEDTRONIC	COM:HEALIONICS	ORG:THETEARSFOUNDATION
Market	PRIVATE	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare	Healthcare & Health Services	Public & Social Sector
Industry	Healthcare	Medical - Devices	Healthcare & Health Services	Nonprofit Organization
Country	CO	IE	US	US
Stage
Employee Count		95K	10
Website	clinicainstitutoocular.com.co	medtronic.com	healionics.com	thetearsfoundation.org
LinkedIn			healionics-corporation
Founders

Metric
Market Cap		98.81B
Enterprise Value
Monthly Web Traffic	1.55K	2.66M
Web Traffic Growth	-0.95	0.29
Valuation
Raised Capital

Metric
Revenue		32.36B
Revenue (LTM)
Revenue (NTM)
Gross Profit		19.45B
EBITDA		8.38B
Operating Income		5.73B
Net Income		3.68B
EPS		2.77
Diluted EPS		2.76
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.66
Operating Profit Margin		0.18
EBITDA Margin		0.26
Net Profit Margin		0.13
Return on Equity		0.08
Return on Assets		0.05
Return on Capital Employed		0.07

COM

CO:COM:CLINICAINSTITUTOOCULAR

Clinica Ocular

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		28.22
P/B Ratio		2.25
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		3.63
EV Multiple		12.19

Metric
Days Sales Outstanding		67.78
Days Payables Outstanding		71.76
Days Inventory Outstanding		187.43
Operating Cycle		254.83
Cash Conversion Cycle		189.62
Asset Turnover		0.36

Metric
Operating Cash Flow		6.79B
Free Cash Flow		5.20B
Cash Flow to Debt		0.27
Operating Cash Flow/Sales		0.21
Free Cash Flow Yield		0.03

Metric
Cash & Equivalents		1.28B
Accounts Receivable		-391M
Inventory		5.22B
Goodwill		40.99B
Debt to Capitalization		0.37
Debt to Assets		0.28
Current Ratio		2.29
Quick Ratio		1.61

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.01
R&D to Revenue		0.08
SG&A to Revenue